カテゴリ： Grand View Research, 世界, 医療/バイオ

スポーツ栄養の世界市場：製品別（ドリンク、サプリメント、食品）、流通経路別（eコマース、店舗販売）、地域別

◆英語タイトル：Sports Nutrition Market Size, Share & Trends Analysis Report By Product (Drinks, Supplements, Foods), By Distribution Channel (Ecommerce, Bricks & Mortar), By Region, And Segment Forecasts, 2020 - 2027
◆商品コード：GV20MY074
◆発行会社（リサーチ会社）：Grand View Research
◆発行日：2020年2月28日
◆ページ数：160
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥624,750見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥729,750見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥939,750見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。
本調査レポートでは、スポーツ栄養の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、製品別（ドリンク、サプリメント、食品）分析、流通経路別（eコマース、店舗販売）分析、地域別分析、競争状況などの構成でお届けいたします。
・調査手法・範囲
・エグゼクティブサマリー
・市場要因・動向・範囲
・スポーツ栄養の世界市場：製品別（ドリンク、サプリメント、食品）
・スポーツ栄養の世界市場：流通経路別（eコマース、店舗販売）
・スポーツ栄養の世界市場：地域別
・競争状況
【レポートの概要】

The global sports nutrition market size is expected to reach USD 31.0 billion by 2027, registering a CAGR of 8.9% over the forecast period, according to a new report by Grand View Research, Inc. Increasing importance of an active lifestyle owing to rise in sedentary jobs and shift in demographic base from core athletes to recreational athletes and lifestyle users are the key factors expected to drive the market. Moreover, increasing number of health and fitness centers and gyms, rising consumer awareness regarding the adoption of a healthy lifestyle, and demand for these products from athletes is expected to boost the market growth.

Widespread product availability due to the presence of large companies is expected to drive the demand for these products. For instance, in 2018, Amazon launched its private label sports supplement brand “OWN PWR” for U.S. consumers. Companies such as Glanbia Plc; Abbott Laboratories Inc.; Neutra Science Labs; Hormel Foods Corporation; and GNC Corporation are the key players operating in the market. Moreover, favorable government initiatives to promote health, growing base of health-conscious population, and rising awareness about sedentary health risks further drive the market.

Moreover, the U.S. population is becoming increasingly health-conscious and hence focuses on adopting an active lifestyle. The International Health, Racquet & Sportsclub Association (IHRSA), a Boston-based, commercial health clubs trade association, reported a 3.6% rise in the number of health club members, from 55.3 million in 2015 to 57.3 million in 2016. The number of health clubs in U.S. increased by 5.2%, from 36,540 in 2016 to 38,447 in 2017. These health clubs and fitness centers have consulting dietitians, which influences the consumption of sports nutrition products among trainers and fitness enthusiasts.

Further key findings from the report suggest:

• Sports supplements emerged as the largest product segment in 2019 with a share of over 80.0% of the global sports nutrition market owing to increasing commercialization of these supplements and wide product range including creatine and whey protein supplements

• On the basis of distribution channel, bricks and mortar dominated the market in 2019 owing to high consumer base for retail stores

• Ecommerce is projected to be the fastest-growing segment over the forecast period owing to increasing popularity of ecommerce platforms and the associated benefits such as discounts and convenience

• North America dominated the global market in 2019 due to growing awareness about nutritional supplements and rise in government initiatives promoting sports-related activities

• Key players operating in the market include Glanbia plc; Hormel Foods Corporation; General Nutrition Centers, Inc.;Abbott; The Coca-Cola Company; and Clif Bar & Company.

【レポートの目次】

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased database:
1.3.1.2 GVR’s internal database
1.3.2 Primary Research:
1.4 Research Scope and Assumptions
1.5 List to Data Sources
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Global Sports Nutrition Snapshot
Chapter 3 Global Sports Nutrition Market Variables, Trends, & Scope
3.1 Penetration and Growth Prospect Mapping
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.2.3 Industry Challenges
3.3 Global Sports Nutrition Market Analysis Tools
3.3.1 Industry Analysis – Porter’s
3.3.1.1 Bargaining power of the suppliers
3.3.1.2 Bargaining power of the buyers
3.3.1.3 Threats of substitution
3.3.1.4 Threats from new entrants
3.3.1.5 Competitive rivalry
3.3.2 PESTEL Analysis
3.3.2.1 Political landscape
3.3.2.2 Economic and Social landscape
3.3.2.3 Technology landscape
3.3.2.4 Legal landscape
3.3.2.5 Technology landscape
Chapter 4 Sports Nutrition Market: Product Type Estimates & Trend Analysis
4.1 Definitions & Scope
4.2 Global Sports Nutrition Market: Product Market Share Analysis, 2019 and 2027
4.3 Sports drinks
4.3.1 Sports drinks analysis market estimates and forecasts, 2016-2027 (USD million)
4.4 Sports supplements
4.4.1 Sports supplements analysis market estimates and forecasts, 2016-2027 (USD million)
4.5 Sports food
4.5.1 Sports food analysis market estimates and forecasts, 2016-2027 (USD million)
Chapter 5 Sports Nutrition Market: Distribution Channel Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Global Sports Nutrition Market: Distribution Channel Market Share Analysis, 2019 and 2027
5.3 E-commerce
5.3.1 E-commerce analysis market estimates and forecasts, 2016-2027 (USD million)
5.4 Bricks and mortar
5.4.1 Bricks and mortar analysis market estimates and forecasts, 2016-2027 (USD million)
Chapter 6 Sports Nutrition Market: Regional Estimates & Trend Analysis, By Product and Distribution Channel
6.1 Global Sports Nutrition Market: Regional Movement Analysis
6.2 North America
6.2.1 North America sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.2.3 Canada
6.2.3.1 Canada sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.3 Europe
6.3.1 Europe sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.3.3 Germany
6.3.3.1 Germany sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.3.4 France
6.3.4.1 France sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.3.5 Italy
6.3.5.1 Italy sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.3.6 Spain
6.3.6.1 Spain sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.4.2 Japan
6.4.2.1 Japan sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.4.3 China
6.4.3.1 China sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.4.4 India
6.4.4.1 India sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.4.5 Australia
6.4.5.1 Australia sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.4.6 New Zealand
6.4.6.1 New Zealand sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.5 Latin America
6.5.1 Latin America sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.5.4 Argentina
6.5.4.1 Argentina sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.6 MEA
6.6.1 MEA sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.6.3 Saudi Arabia
6.6.3.1 Saudi Arabia sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
6.6.4 UAE
6.6.4.1 UAE sports nutrition market estimates and forecasts by product and distribution channel, 2016 – 2027 (USD Million)
Chapter 7 Competitive Landscape
7.1 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
7.2 Company Profiles
7.3 Glanbia Plc
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Product benchmarking
7.3.4 Strategic initiatives
7.4 AirStrip Technologies
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Product benchmarking
7.4.4 Strategic initiatives
7.5 Hormel Foods Corporation
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Product benchmarking
7.5.4 Strategic initiatives
7.6 General Nutrition Centers, Inc.
7.6.1 Company overview
7.6.2 Financial performance
7.6.3 Product benchmarking
7.6.4 Strategic initiatives
7.7 Abbott
7.7.1 Company overview
7.7.2 Financial performance
7.7.3 Product benchmarking
7.7.4 Strategic Initiatives
7.8 Science in Sport
7.8.1 Company overview
7.8.2 Financial performance
7.8.3 Product benchmarking
7.8.4 Strategic initiatives
7.9 The Hut Group
7.9.1 Company overview
7.9.2 Financial performance
7.9.3 Product benchmarking
7.9.4 Strategic Initiatives
7.10 Iovate Health Sciences International Inc.
7.10.1 Company overview
7.10.2 Financial performance
7.10.3 Product benchmarking
7.10.4 Strategic Initiatives
7.11 Cardiff Sports Nutrition LTD.
7.11.1 Company overview
7.11.2 Financial performance
7.11.3 Product benchmarking
7.11.4 Strategic Initiatives
7.12 Clif Bar & Company
7.12.1 Company overview
7.12.2 Financial performance
7.12.3 Product benchmarking
7.12.4 Strategic Initiatives
7.13 MUSCLEPHARM
7.13.1 Company overview
7.13.2 Financial performance
7.13.3 Product benchmarking
7.13.4 Strategic Initiatives
7.14 Nature’s Bounty
7.14.1 Company overview
7.14.2 Financial performance
7.14.3 Product benchmarking
7.14.4 Strategic Initiatives
7.15 POST HOLDINGS, INC.
7.15.1 Company overview
7.15.2 Financial performance
7.15.3 Product benchmarking
7.15.4 Strategic Initiatives

List of Tables

TABLE 1 Ongoing projects for CAR T-cell therapies
TABLE 2 Non-viral DNA vectors (non-replicating) in gene therapy trials
TABLE 3 Some of the examples of molecules under development based on lentiviral vectors
TABLE 4 Molecules in development based on AAV vectors
TABLE 5 North America gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 6 North America gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 7 U.S. gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 8 U.S. gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 9 Canada gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 10 Canada gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 11 Europe gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 12 Europe gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 13 Asia Pacific gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 14 Asia Pacific gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 15 China gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 16 China gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 17 Japan gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 18 Japan gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 19 Russia gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 20 Russia gene therapy market, by vector type, 2016 - 2027 (USD Million)
TABLE 21 Australia gene therapy market, by indication, 2016 - 2027 (USD Million)
TABLE 22 Australia gene therapy market, by vector type, 2016 - 2027 (USD Million)


List of Figures

FIG. 1 Market summary (USD Million)
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Global gene therapy pipeline as of 2017, by phase of trial
FIG. 12 Global cancer incidence, as of September 2018
FIG. 13 Market restraint relevance analysis (Current & future impact)
FIG. 14 Gene therapy prices by eligible patients per year
FIG. 15 Annual Investment in the CAR-T Space, 2013 - 2026
FIG. 16 Global financings in cell therapy, 2016-2018
FIG. 17 Recent and ongoing manufacturing capacity expansions for viral vector and large-scale cell therapies, as of 2017
FIG. 18 SWOT Analysis, By Factor (Political & legal, economic and technological)
FIG. 19 Porter’s Five Forces Analysis
FIG. 20 Gene therapy market: Indication outlook key takeaways
FIG. 21 Gene therapy market: Indication movement analysis
FIG. 22 Global gene therapy market for Acute Lymphoblastic Leukemia (ALL), 2016 - 2027 (USD Million)
FIG. 23 Global gene therapy market for inherited retinal disease, 2016 - 2027 (USD Million)
FIG. 24 Global gene therapy market for large B-cell lymphoma, 2016 - 2027 (USD Million)
FIG. 25 Global gene therapy market for ADA-SCID, 2016 - 2027 (USD Million)
FIG. 26 Global gene therapy market for melanoma (lesions), 2016 - 2027 (USD Million)
FIG. 27 Global gene therapy market for Beta-Thalassemia Major/SCD, 2016 - 2027 (USD Million)
FIG. 28 Global gene therapy market for head & neck squamous cell carcinoma, 2016 - 2027 (USD Million)
FIG. 29 Global gene therapy market for peripheral arterial disease, 2016 - 2027 (USD Million)
FIG. 30 Global gene therapy market for Spinal Muscular Atrophy (SMA), 2016 - 2027 (USD Million)
FIG. 31 Global gene therapy market for other indications, 2016 - 2027 (USD Million)
FIG. 32 Gene therapy market vector type outlook: Key takeaways
FIG. 33 Gene therapy market: Vector type movement analysis
FIG. 34 Global lentivirus-based gene therapy market, 2016 - 2027 (USD Million)
FIG. 35 Global AAV-based gene therapy market, 2016 - 2027 (USD Million)
FIG. 36 Global retrovirus and gammaretrovirus vector-based gene therapy market, 2016 - 2027 (USD Million)
FIG. 37 Global modified herpes simplex virus vectors-based gene therapy market, 2016 - 2027 (USD Million)
FIG. 38 Global adenovirus vectors-based gene therapy market, 2016 - 2027 (USD Million)
FIG. 39 Global non-viral plasmid vector-based gene therapy market, 2016 - 2027 (USD Million)
FIG. 40 Regional market place: Key takeaways
FIG. 41 Stem cells & non-stem cells regional outlook, 2019 & 2027
FIG. 42 North America gene therapy market, 2016 - 2027 (USD Million)
FIG. 43 U.S. gene therapy market, 2016 - 2027 (USD Million)
FIG. 44 Canada gene therapy market, 2016 - 2027 (USD Million)
FIG. 45 Europe gene therapy market, 2016 - 2027 (USD Million)
FIG. 46 Asia Pacific gene therapy market, 2016 - 2027 (USD Million)
FIG. 47 China gene therapy market, 2016 - 2027 (USD Million)
FIG. 48 Japan gene therapy market, 2016 - 2027 (USD Million)
FIG. 49 Russia gene therapy market, 2016 - 2027 (USD Million)
FIG. 50 Australia gene therapy market, 2016 - 2027 (USD Million)
FIG. 51 Strategy framework

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[スポーツ栄養の世界市場：製品別（ドリンク、サプリメント、食品）、流通経路別（eコマース、店舗販売）、地域別]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 性具の世界市場：タイプ別（女性、男性）、流通経路別（Eコマース、専門店、量販店）、セグメント予測
    GV9DE031 / Grand View Research / 2019年10月3日 / 本レポートでは、性具の世界市場について、調査手法・範囲、エグゼクティブサマリ－、市場変数・傾向、タイプ別（女性、男性）分析、流通経路別（Eコマース、専門店、量販店）分析、地域別分析、競合分析などを総合的、多面的に調査・分析しました。 ・調査手法・範囲 ・エグゼクティブサマリ－ ・市場変数・傾向 ・性具の世界市場：タイプ別（女性、男性） ・性具の世界市場：流通経路別（Eコマース、専門店、量販店） ・性具の世界市場：地域別分析 ・競合状況...The global sex toys market size is expected to reach USD 52.7 billion by 2026, based on a new report by Grand View Research, Inc., exhibiting a CAGR of 9.1%. Use of innovative technology for designing and manufacturing of sex toy is anticipated to augment growth during the forecast period. Users are moving from traditional vibrators and penile rings to devices that can be operated via mobile applications. In April 2017, We-Vibe, a Canadian manufacturer, launched its two-way controlled We-Connect app that was made available free of cost on Apple and Android devices. The company reported 2 million customers are...
  2. 降圧薬の世界市場：治療クラス別（利尿薬、ACE阻害薬、カルシウムチャネル遮断薬、血管拡張薬、ベータアドレナリン遮断薬、その他）、流通経路別（小売薬局、病院薬局、Eコマース、その他）
    AMR20FE071 / Allied Market Research / 2019年12月31日 / 本調査レポートでは、降圧薬の世界市場について調べ、イントロダクション、エグゼクティブサマリー、市場概要、治療クラス別（利尿薬、ACE阻害薬、カルシウムチャネル遮断薬、血管拡張薬、ベータアドレナリン遮断薬、その他）分析、流通経路別（小売薬局、病院薬局、Eコマース、その他）分析、地域別分析、企業概要などを総合的、多面的にまとめております。 ・イントロダクション ・エグゼクティブサマリ－ ・市場概要 ・降圧薬の世界市場：治療クラス別（利尿薬、ACE阻害薬、カルシウムチャネル遮断薬、血管拡張薬、ベータアドレナリン遮断薬、その他） ・降圧薬の世界市場：流通経路別（小売薬局、病院薬局、Eコマース、その他） ・降圧薬の世界市場：地域別 ・企業概要...The global antihypertensive market accounted for $22,557 million in 2018, and is expected to reach $28,797 million by 2026, registering a CAGR of 3.1% from 2019 to 2026. Antihypertensive drugs are employed for the treatment of patients suffering from hypertension. Hypertension is a medical condition, which involves rise in blood pressure in the arteries. Furthermore, the patient suffering from hypertension is highly susceptible to other complications, which include heart failure and aneurysm. Therefore, the treatment of this medical condition requires early diagnosis and management by the use of antihypertensive drugs. Some of the antihypertensive drugs available in the market include...
  3. 糖尿病デバイスの世界市場：製品別（BGMデバイス、インスリン送達デバイス）、流通経路別、最終用途別（病院、在宅医療）、地域別
    GV20MY047 / Grand View Research / 2020年2月17日 / 本調査レポートでは、糖尿病デバイスの世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、製品別（BGMデバイス、インスリン送達デバイス）分析、流通経路別（病院薬局、小売薬局、糖尿病クリニック/センター、オンライン薬局、その他）分析、最終用途別（病院、在宅医療、診断センター）分析、地域別分析、競争状況などの構成でお届けいたします。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場要因・動向・範囲 ・糖尿病デバイスの世界市場：製品別（BGMデバイス、インスリン送達デバイス） ・糖尿病デバイスの世界市場：流通経路別（病院薬局、小売薬局、糖尿病クリニック/センター、オンライン薬局、その他） ・糖尿病デバイスの世界市場：最終用途別（病院、在宅医療、診断センター） ・糖尿病デバイスの世界市場：地域別 ・競争状況...The global diabetes devices market size is expected to reach USD 41.6 billion by 2027, registering a CAGR of 7.8% over the forecast period, according to a new report by Grand View Research, Inc. The market is driven by factors such as increasing incidence of diabetes, technological advancements, and innovative product launches. Increasing adoption of advanced diabetes management solutions in developing region, government policies, and rising medical tourism are some of the major factors contributing to the market growth. Furthermore, rising government initiatives to spread awareness about diabetes and increasing R&D expenditure of major players are the factors expected to...
  4. コンタクトレンズの世界市場：材料別（ガス透過性、シリコーンハイドロゲル）、デザイン別、用途別、流通経路別、地域別、セグメント予測
    GV9DE011 / Grand View Research / 2019年11月14日 / 本レポートでは、コンタクトレンズの世界市場について調査手法および範囲、エグゼクティブサマリ－、変数・傾向、材料別（ガス透過性、シリコーンハイドロゲル）分析、デザイン別（球面レンズ、トーリックレンズ、多焦点レンズ、その他）分析、用途別（矯正、治療、コスメ、補綴、ライフスタイル）分析、流通経路別（Eコマース、小売）分析、地域別分析、競合状況などを総合的、多面的に調査・分析しました。 ・調査手法および範囲 ・エグゼクティブサマリ－ ・コンタクトレンズ市場：変数・傾向 ・コンタクトレンズの世界市場：材料別（ガス透過性、シリコーンハイドロゲル） ・コンタクトレンズの世界市場：デザイン別（球面レンズ、トーリックレンズ、多焦点レンズ、その他） ・コンタクトレンズの世界市場：用途別（矯正、治療、コスメ、補綴、ライフスタイル） ・コンタクトレンズの世界市場：流通経路別（Eコマース、小売） ・コンタクトレンズの世界市場：地域別分析 ・競合状況...The global contact lenses market size is expected to reach USD 17.7 billion by 2025, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 5.6% from 2019 to 2025. The use of innovative materials for manufacturing contact lenses and increasing adoption of contact lenses are prominent factors boosting the growth of the market. The rising tendency of youngsters to enhance their aesthetic appearance and growing aging population is expected to drive the market over the forecast period. Also, global factors such as the rising disposable income and improvement in...
  5. 補完代替医療の世界市場：インターベンション別（磁気、エネルギーヒーリング）、流通経路別（Eセールス、直接販売）、地域別
    GV20MY040 / Grand View Research / 2020年2月19日 / 本調査レポートでは、補完代替医療の世界市場について調査・分析し、調査手法、エグゼクティブサマリー、市場要因・動向・範囲、競争分析、インターベンション別（磁気、エネルギーヒーリング）分析、流通経路別（Eセールス、直接販売）分析、地域別分析、競争状況などの構成でお届けいたします。 ・調査手法 ・エグゼクティブサマリー ・市場要因・動向・範囲 ・競争分析 ・補完代替医療の世界市場：インターベンション別（磁気、エネルギーヒーリング） ・補完代替医療の世界市場：流通経路別（Eセールス、直接販売） ・補完代替医療の世界市場：地域別 ・競争状況...The global complementary and alternative medicine market size is projected to reach USD 296.3 billion by 2027, exhibiting a CAGR of 19.9%, according to a new report by Grand View Research, Inc. A comparatively high demand for alternative medicine across developing countries and expanding applications of traditional medicine practiced in Asia are two key driving factors of the market. China and India are the key contributors to the Asia Pacific region and thus are offering significant momentum to the revenue generation by complementary and alternative treatment through the study period. In addition, increase in the number of licensed and trained...
  6. 消化酵素の世界市場：由来別（動物、植物、微生物、その他）、用途別（サプリメント、医療・乳幼児向け栄養、スポーツ栄養）、地域別予測
    BZW9JN028 / Bizwit Research & Consulting / 2019年1月2日 / 本資料は、消化酵素の世界市場について調べ、消化酵素の世界規模、市場動向、市場環境、由来別（動物、植物、微生物、その他）分析、用途別（サプリメント、医療・乳幼児向け栄養、スポーツ栄養）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。業界の主要なプレイヤーはKlaire Laboratories、AMD Telecom S.A.、Enzymes Inc.、Proteozymes、National Enzyme Company、Enzymedica、AST Enzymes、VEMO 99 OOD、Advanced...Global Digestive Enzyme Market to reach USD XX billion by 2025. Global Digestive Enzyme Market valued approximately USD XX billion in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The Digestive Enzyme Market is continuously growing on surging trend in global scenario over the coming years. The major driving factor of global Digestive Enzyme market are increasing prevalence of lifestyle-oriented diseases and increasing consumer expenditure on food supplements. In addition, rising geriatric population and age-associated GI disorders coupled with rising concerns towards stomach health are some other factors which...
  7. 世界の使い捨てラテックス手袋市場2020-2027：製品種類別（無菌、非無菌）、流通経路別、用途別、地域別
    BZW20PL073 / Bizwit Research & Consulting / 2020年8月7日 / 本調査レポートでは、使い捨てラテックス手袋の世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、市場分析、製品種類別（無菌、非無菌）分析、流通経路別分析、用途別分析、地域別分析、競争状況、調査プロセスなどを含め、以下の構成でご提供いたします。 ・エグゼクティブサマリー ・市場定義・範囲 ・市場動向 ・市場分析 ・使い捨てラテックス手袋の世界市場規模：製品種類別（無菌、非無菌） ・使い捨てラテックス手袋の世界市場規模：流通経路別 ・使い捨てラテックス手袋の世界市場規模：用途別 ・使い捨てラテックス手袋の世界市場規模：地域別 ・競争状況...Global Disposable Latex Gloves Market is valued at approximately USD XXX million in 2019 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2020-2027. Latex is an organic material that is separated from flowering plants. This can also be made unnaturally by polymerizing a monomer as a styrene, which is blended by surfactants. These materials are typically used for the manufacture of latex gloves for surgical and physical inspection. These gloves are frequently used in healthcare practices and it has a common application among medical professionals. Latex gloves are also biodegradable...
  8. 世界のウェアラブル医療機器市場2020-2027：新型コロナの影響、種類別（活動モニター、スマートウォッチ、スマート服、その他）、流通経路別、機器種類別、用途別、地域別
    BZW20PL279 / Bizwit Research & Consulting / 2020年8月11日 / 本調査レポートでは、ウェアラブル医療機器の世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、市場分析、種類別（活動モニター、スマートウォッチ、スマート服、その他）分析、流通経路別分析、機器種類別分析、用途別分析、地域別分析、競争状況、調査プロセスなどを含め、以下の構成でご提供いたします。 ・エグゼクティブサマリー ・市場定義・範囲 ・市場動向 ・市場分析 ・ウェアラブル医療機器の世界市場規模：種類別（活動モニター、スマートウォッチ、スマート服、その他） ・ウェアラブル医療機器の世界市場規模：流通経路別 ・ウェアラブル医療機器の世界市場規模：機器種類別 ・ウェアラブル医療機器の世界市場規模：用途別 ・ウェアラブル医療機器の世界市場規模：地域別...Global Wearable Medical Devices Market is valued approximately USD XX billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.1% over the forecast period 2020-2027. Wearable medical devices are the devices that are attached, worn or handheld devices which monitor and analyze metabolic changes that happen in the body as well as record data. Such devices have always been portable, user-friendly as well as non-invasive devices. Wearable medical devices are used to monitor blood sugar levels, blood pressure levels, heart rate, sleep patterns, sleep apnea disease, skin temperature, etc., creating results in very...
  9. 世界の降圧薬市場2020-2027：治療クラス別（利尿薬、アンジオテンシン変換酵素（ACE）阻害剤、カルシウムチャネル遮断薬、血管拡張薬、ベータアドレナリン遮断薬、その他）、流通経路別、地域別
    BZW20PL013 / Bizwit Research & Consulting / 2020年8月7日 / 本調査レポートでは、降圧薬の世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、市場分析、治療クラス別（利尿薬、アンジオテンシン変換酵素（ACE）阻害剤、カルシウムチャネル遮断薬、血管拡張薬、ベータアドレナリン遮断薬、その他）分析、流通経路別分析、地域別分析、競争状況、調査プロセスなどを含め、以下の構成でご提供いたします。 ・エグゼクティブサマリー ・市場定義・範囲 ・市場動向 ・市場分析 ・降圧薬の世界市場規模：治療クラス別（利尿薬、アンジオテンシン変換酵素（ACE）阻害剤、カルシウムチャネル遮断薬、血管拡張薬、ベータアドレナリン遮断薬、その他） ・降圧薬の世界市場規模：流通経路別 ・降圧薬の世界市場規模：地域別 ・競争状況 ・調査プロセス...Global Antihypertensive Drugs Market is valued at approximately USD 23.2 million in 2019 and is anticipated to grow with a healthy growth rate of more than 3.1% over the forecast period 2020-2027. Antihypertensive drug is the class of drug used in the treatment of hypertension (high blood pressure). Hypertension is one of the leading causes of heart complications, such as heart failure, heart attack, and dementia. Thus, the treatment of hypertension must be integrated into an overall program to manage factors that intensify the risk of cardiovascular events (such as stroke and myocardial infarction). Therefore, there are a variety of...
  10. 糖尿病性神経障害の世界市場：疾患の種類別（自律神経障害、末梢神経障害、近位筋優位遺伝性運動感覚ニューロパチー、限局性神経障害）、治療別（薬物、理学療法、放射線療法、その他）、流通経路別（診療所、病院、薬局）、地域別予測
    BZW9MR024 / Bizwit Research & Consulting / 2019年3月7日 / 本資料は、糖尿病性神経障害の世界市場について調べ、糖尿病性神経障害の世界規模、市場動向、市場環境、疾患の種類別（自律神経障害、末梢神経障害、近位筋優位遺伝性運動感覚ニューロパチー、限局性神経障害）分析、治療別（薬物、理学療法、放射線療法、その他）分析、流通経路別（診療所、病院、薬局）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。業界の主要なプレイヤーはPfizer Inc.、 Janssen Pharmaceuticals, Inc.、 Eli Lilly and Company、 Cephalon,...Global diabetic neuropathy market to reach USD 5.8 billion by 2025. Global diabetic neuropathy market is valued approximately USD 3.8 billion in 2017 and is anticipated to grow with a healthy growth rate of more than 5.4 % over the forecast period 2018-2025. Key trends in the market is advent of new therapeutics for treatment of neuropathy and favorable reimbursement scenario which is expected to foster the growth of the diabetic neuropathy market. For instance: In 2016 as per the University of Cambridge, researchers have led to the development of a new approach to treatment of neuropathic pain. Further, the...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆